233 related articles for article (PubMed ID: 12845951)
1. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
Chen CY; Lin XZ; Tsao HC; Shiesh SC
Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
[TBL] [Abstract][Full Text] [Related]
2. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
Chen CY; Shiesh SC; Tsao HC; Lin XZ
Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
[TBL] [Abstract][Full Text] [Related]
3. The value of biliary amylase and Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-associated Protein I (HIP/PAP-I) in diagnosing biliary malignancies.
Chen CY; Lin XZ; Wu HC; Shiesh SC
Clin Biochem; 2005 Jun; 38(6):520-5. PubMed ID: 15885230
[TBL] [Abstract][Full Text] [Related]
4. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
[TBL] [Abstract][Full Text] [Related]
5. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
7. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
8. [Fibronectin in human bile--a new parameter for diagnosis of malignant bile duct processes?--A pilot study].
Körner T; Kropf J; Jaspersen D; Schorr W; Hammar CH; Gressner AM
Z Gastroenterol; 1994 Feb; 32(2):87-90. PubMed ID: 8165831
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin in human bile fluid for diagnosis of malignant biliary diseases.
Körner T; Kropf J; Hackler R; Brenzel A; Gressner AM
Hepatology; 1996 Mar; 23(3):423-8. PubMed ID: 8617420
[TBL] [Abstract][Full Text] [Related]
10. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma.
Principe A; Ercolani G; Bassi F; Paolucci U; Raspadori A; Turi P; Beltempo P; Grazi GL; Cavallari A
Hepatogastroenterology; 2003; 50(53):1246-9. PubMed ID: 14571710
[TBL] [Abstract][Full Text] [Related]
12. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
13. Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis.
Beyazit Y; Kekilli M; Ibis M; Kurt M; Sayilir A; Onal IK; Purnak T; Oztas E; Tas A; Yesil Y; Arhan M
Hepatogastroenterology; 2012; 59(117):1469-73. PubMed ID: 22683963
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
Li YG; Zhang N
Dig Liver Dis; 2009 Aug; 41(8):605-8. PubMed ID: 19168405
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma.
Tangkijvanich P; Thong-ngam D; Theamboonlers A; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Hepatogastroenterology; 2004; 51(55):15-9. PubMed ID: 15011822
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
17. Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis ?
John AR; Haghighi KS; Taniere P; Esmat ME; Tan YM; Bramhall SR
Dig Surg; 2006; 23(5-6):319-24. PubMed ID: 17170527
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy.
Cheon YK; Cho YD; Moon JH; Jang JY; Kim YS; Kim YS; Lee MS; Lee JS; Shim CS
Am J Gastroenterol; 2007 Oct; 102(10):2164-70. PubMed ID: 17617204
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
[TBL] [Abstract][Full Text] [Related]
20. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma.
Hamada S; Satoh K; Hirota M; Kanno A; Ishida K; Umino J; Ito H; Kikuta K; Kume K; Masamune A; Katayose Y; Unno M; Shimosegawa T
Cancer Sci; 2011 Jan; 102(1):150-6. PubMed ID: 21029254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
